Previous studies have shown that stimulation of coinhibitory molecules, such as CTLA-4 and BTLA, suppressed pro-atherogenic T- and B cell immunity and decreased atherosclerosis development in ApoE−/− and Ldlr−/− mice, respectively (23, 24). The gene discussed is CTLA4; the disease is atherosclerosis.